Table 2.
Best response | n (%) | Duration (months) |
---|---|---|
Complete response | 1 (4) | 77 |
Partial response | 16 (62) | 19 |
Stable disease | 6 (23) | 6 |
Disease progression | 1 (4) | (−) |
No further evaluation* | 2 (8) | (−) |
Two patients experienced clinical deterioration/death prior to evaluation by imaging.